The use of selected nutrition supplements and complementary and alternative medicine in liver disease - PubMed (original) (raw)
Review
The use of selected nutrition supplements and complementary and alternative medicine in liver disease
A James Hanje et al. Nutr Clin Pract. 2006 Jun.
Abstract
Almost all patients with liver disease, especially advanced liver disease, have some evidence of malnutrition, including mineral/vitamin deficiency. A major health trend in the United States has been the significant growth in the use of complementary and alternative medicine (CAM), including nutrition supplements and herbal agents. In the 1990s, the United States government created the National Center for Complementary and Alternative Medicine (NCCAM), as well as the Office on Dietary Supplements, to extend our knowledge in these areas. CAM users are often highly educated and frequently use CAM therapy for chronic diseases, including chronic liver disease. Indeed, most studies suggest that patients with chronic liver disease frequently use nutrition supplements and CAM agents in addition to their traditional medicines. The purpose of this review is to provide an update on the role of nutrition supplements and herbals in liver disease. This article will focus mainly on 7 selected agents (vitamin E, zinc, magnesium, S-adenosylmethionine, betaine, silymarin, and glycyrrhizin), for which there have been not only in vitro and animal studies but also human clinical trials, and we will review both potential efficacy and safety issues.
Figures
Figure 1
Betaine facilitates methionine regeneration from homocysteine.
Similar articles
- Nutritional supplements and alternative medicine.
Krueger KJ, McClain CJ, McClave SA, Dryden GW. Krueger KJ, et al. Curr Opin Gastroenterol. 2004 Mar;20(2):130-8. doi: 10.1097/00001574-200403000-00014. Curr Opin Gastroenterol. 2004. PMID: 15703634 - The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.
Kantor M. Kantor M. J Am Coll Radiol. 2009 Apr;6(4):254-62. doi: 10.1016/j.jacr.2008.09.012. J Am Coll Radiol. 2009. PMID: 19327658 - Alternative medicines and the liver.
Fogden E, Neuberger J. Fogden E, et al. Liver Int. 2003 Aug;23(4):213-20. doi: 10.1034/j.1600-0676.2003.00843.x. Liver Int. 2003. PMID: 12895259 Review. - Complementary and alternative medicine in hepatology: review of the evidence of efficacy.
Verma S, Thuluvath PJ. Verma S, et al. Clin Gastroenterol Hepatol. 2007 Apr;5(4):408-16. doi: 10.1016/j.cgh.2006.10.014. Epub 2007 Jan 11. Clin Gastroenterol Hepatol. 2007. PMID: 17222587 Review.
Cited by
- Current Pharmacotherapy and Nutrition Therapy of Alcohol-Associated Liver Disease.
Hardesty JE, McClain CJ. Hardesty JE, et al. Clin Liver Dis. 2024 Nov;28(4):731-745. doi: 10.1016/j.cld.2024.06.018. Epub 2024 Aug 13. Clin Liver Dis. 2024. PMID: 39362718 Review. - Association of insulin-like growth factor II mrna-binding protein 3 (IMP3) expression with prognostic and morphological factors in endometrial cancer.
Salum SOR, Candido EB, Domingues MAC, Ojopi EPB, Tonon ÂFS, da Silva-Filho AL. Salum SOR, et al. Rev Bras Ginecol Obstet. 2024 Jul 26;46:e-rbgo61. doi: 10.61622/rbgo/2024rbgo61. eCollection 2024. Rev Bras Ginecol Obstet. 2024. PMID: 39176196 Free PMC article. - The effects of silymarin consumption on inflammation and oxidative stress in adults: a systematic review and meta-analysis.
Bahari H, Shahraki Jazinaki M, Rashidmayvan M, Taheri S, Amini MR, Malekahmadi M. Bahari H, et al. Inflammopharmacology. 2024 Apr;32(2):949-963. doi: 10.1007/s10787-023-01423-6. Epub 2024 Feb 19. Inflammopharmacology. 2024. PMID: 38372848 - Highlighting the Use of the Hepatoprotective Nutritional Supplements among Patients with Chronic Diseases.
Foghis M, Tit DM, Bungau SG, Ghitea TC, Pallag CR, Foghis AM, Behl T, Bustea C, Pallag A. Foghis M, et al. Healthcare (Basel). 2023 Oct 6;11(19):2685. doi: 10.3390/healthcare11192685. Healthcare (Basel). 2023. PMID: 37830722 Free PMC article. - Thermodynamic Assessment of the Effects of Intermittent Fasting and Fatty Liver Disease Diets on Longevity.
Öngel ME, Yildiz C, Başer Ö, Yilmaz B, Özilgen M. Öngel ME, et al. Entropy (Basel). 2023 Jan 25;25(2):227. doi: 10.3390/e25020227. Entropy (Basel). 2023. PMID: 36832594 Free PMC article.
References
- McClain CJ, Hill DB, Kugelmas M, Marsano L. Nutrition and liver disease. In: Bowman B, Russell RM, editors. Present Knowledge in Nutrition. ILSI Press; Washington, DC: 2001. pp. 483–496.
- Mendenhall C, Roselle GA, Gartside P, Moritz T. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration cooperative studies. Alcohol Clin Exp Res. 1995;19:635–641. - PubMed
- Mendenhall CL, Tosch T, Weesner RE, et al. VA cooperative study on alcoholic hepatitis II: prognostic significance of protein-calorie malnutrition. Am J Clin Nutr. 1986;43:213–218. - PubMed
- Mendenhall CL, Anderson S, Weesner RE, Goldberg SJ, Krolik KA. Protein-calorie malnutrition associated with alcoholic hepatitis. Am J Med. 1984;76:211–222. - PubMed
- Mendenhall CL, Moritz TE, Roselle GA, et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs Cooperative Study. Hepatology. 1993;17:564–576. - PubMed
Publication types
MeSH terms
Grants and funding
- R01AA015970/AA/NIAAA NIH HHS/United States
- R01AA010496/AA/NIAAA NIH HHS/United States
- R01 AA014185/AA/NIAAA NIH HHS/United States
- R01DK071765/DK/NIDDK NIH HHS/United States
- R01 DK071765/DK/NIDDK NIH HHS/United States
- K24AA000297/AA/NIAAA NIH HHS/United States
- R37AA010762/AA/NIAAA NIH HHS/United States
- R01 AA015970/AA/NIAAA NIH HHS/United States
- K24 AA000297/AA/NIAAA NIH HHS/United States
- R01AA014185/AA/NIAAA NIH HHS/United States
- R37 AA010762/AA/NIAAA NIH HHS/United States
- R01 AA010496/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical